Management tracks: AstraZeneca, Certara, Longas

AstraZeneca plc (LSE:AZN; NYSE:AZN) said Sunil Verma will become VP, head of breast cancer strategy and global clinical leader in R&D oncology. Verma was head

Read the full 259 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE